500 Global is a multi-stage venture capital firm with $2.4 billion in assets under management. The firm invests in founders who are building fast-growing technology companies. It focuses on markets where technology, innovation, and capital can generate long-term value and economic growth. 500 Global collaborates with key stakeholders and provides advisory services to governments on fostering entrepreneurial ecosystems to support startups. The firm has invested in over 5,000 founders and more than 2,800 companies across 80+ countries. It has funded over 35 companies valued at more than $1 billion and over 160 companies valued at over $100 million, including those that are private, public, or have exited. The team consists of over 190 members based in more than 25 countries, with experience as entrepreneurs, investors, and operators from leading technology companies.

500 Global

Each of the 20 companies accepted into the SkyDeck full cohort will receive investment of $200,000 from the Berkeley SkyDeck Fund. Each of the 10 startups accepted into SkyDeck Europe will receive investment of €145,000 from our dedicated European Fund. Berkeley SkyDeck is UC Berkeley’s global startup accelerator. Named in Forbes as a top five U.S. university accelerator, SkyDeck combines hands-on mentorship with the vast resources of its research university. Participating startups have access to SkyDeck’s 480 advisors, 50 industry partners, and a network of more than 510,000 UC Berkeley alumni.

SkyDeck Berkeley

500 Emerging Europe assists emerging European founders in expanding globally.

500 Emerging Europe

Techstars is a global platform that provides investment and innovation. Through the Techstars Worldwide Entrepreneur Network, founders and their teams connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporate partners who will help their companies grow. Techstars operates four divisions: Techstars Mentorship-Driven Accelerator Program supercharges success and Techstars Startup Programs inspire, educate, and connect entrepreneurs. Techstars Venture Capital Fund invests in innovative and disruptive companies. Techstars Corporate Innovation Partnerships help brands create products and services. Techstars' accelerator portfolio includes more than 1,000 companies with a market cap of $8.1 billion.

Techstars

Over the years Gunung Sewu Group has thrived through visionary leadership recognizing unique growth opportunities, forecasting the evolution of new markets and consistently investing in and strengthening our core businesses.

Gunung Sewu Group

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. They develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Their Research and Development activities are based on a profound understanding of the biochemical processes in living organisms.

Bayer Pharmaceuticals

MINDSHIFT Capital is focused on post-seed early-stage companies in the U.S., Europe and Middle East. Through a global network, MINDSHIFT identifies companies with scalable technology, exceptional leadership and high growth potential. they invest with a gender lens, ensuring diversity of thought while narrowing the funding gap for female-led ventures.

Mindshift Capital

Draper Associates is an early-stage venture capital firm that invests in industry-transforming companies. They invest globally, in great teams of people creating revolutionary companies in new media, gaming, SaaS, cloud, new finance, IOT, and mobile. Their portfolio companies disrupting markets in the tens of billions and are on a clear path to later rounds of fundraising. Draper Associates encourages entrepreneurs to drive their businesses to greatness, to transform industries with new technologies, and to build platforms for extraordinary growth, jobs, and wealth creation. It was founded in 2015 and is headquartered in San Mateo, CA, USA.

Draper Associates

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Otsuka Holdings

Revo Capital (www.revo.vc) is the leading venture capital in Turkey with $188M AUM and was founded at the end of 2013. Having completed the final close of its €90M second fund in October 2021, Revo continues to invest in seed to early and growth-stage startups in Turkey, Eastern Europe and Baltics, and has made 27 investments to-date. Fund’s anchor investors include notable institutions such as IFC, EBRD, EIF and DEG.  Some of fund’s key investments include, but are not limited to Getir, global q-commerce decacorn, PayCore, provider of end-to-end payment solutions and the region’s largest processor; Massive Bio, AI-enabled oncology clinical trial platform; and V-Count, e-commerce style visitor analytics platform for the physical world.

Revo Capital

Halogen Ventures is a Los Angeles, California-based Venture Capital fund focused on investing in early-stage consumer technology startups with a female on the founding team. Halogen Ventures invests in pre-seed, seed, and series A companies creating groundbreaking technologies and products in the consumer space. It is hands-on and supports founders through their full lifecycle. The firm helps them build their networks, get brand exposure, hire great talent, raise follow-on rounds and find their path to acquisition or IPO.

Halogen Ventures

Global Ventures is an international venture capital firm, investing in founders and ideas across emerging markets. The Global Ventures team is a diverse, collaborative, talented, and curious group of professionals who, combined, have years of experience and expertise building and scaling companies.

Global Ventures

ONCE Ventures, the venture capital arm of Otsuka’s Nutraceuticals division, seeks to deliver a healthier and more sustainable future by empowering visionaries and innovators.

ONCE Ventures

IIstanbul Technical University is a state university founded as the Imperial School of Naval Engineering of the Ottoman Empire. ITU currently offers graduate and postgraduate education in a wide range of fields today. It has more than 30,000 full-time students across five campuses located in Istanbul. The university employs around 1,130 faculty members, and 1,300 research assistants in 13 faculties and 6 research institutes.  Times Higher Education has ranked ITU as the 165th university worldwide in 2014 and 8th university in BRICS & Emerging Economies in 2015. ITU has developed a range of entrepreneurship and innovation platforms for commercializing technology-based knowledge and for facilitating entrepreneurial ecosystem: ITU TEKNOKENT, established in 2002, is one of the largest technology parks of Turkey with its 100,000 square meters area, over 2,000 completed R&D projects, 160 companies with more than 5200 employees.  ITU Teknokent generates $137M  total income and $110M R&D exports in 2014. ITU CEKIRDEK is the most comprehensive and unique pre-incubator, incubator, and accelerator of Turkey. With its own branded entrepreneurship competition, it attracts thousands of applications and awards seed capital, for example at TRY100,000, TRY50,000 and 2 x TRY25,000 to leading startups in 2014. ITU GINOVA Center for Entrepreneurship and Innovation is established in 2012 by a group of faculty members from ITU Management Engineering Department. It aims to diffuse entrepreneurship culture among Istanbul Technical University (ITU) students and faculty; inspire and encourage ITU students and faculty towards creative thinking and innovation; to provide them with entrepreneurial skills and competencies; as well as to conduct research on innovation and entrepreneurship to expand knowledge in these areas, with passion for innovation, courage, creativity, and learning by doing.

Istanbul Technical University

Caucasus Ventures is a venture capital firm.

Caucasus Ventures

Vivoo

Vivoo is the world’s first at-home health tracker that uses urine tests to provide personalized lifestyle and nutritional advice based on your results. Vivoo tracks Vitamin C, Salinity, Oxidative Stress, Calcium, pH, Hydration and Ketones. You can get your results in just 60 seconds in the comfort of your home. Take the wheel with your health and wellness journey now - we are here for you every step of the way.  The company was founded in 2017 and is based in San Francisco, California.

Vivoo is a passive remote monitoring platform that provides nutrition and lifestyle insights based on 9 health metrics including hydration, pH balance, ketone, and calcium collected through the individual’s weekly urine tests. The urine analysis process involves users urinating on the test strip, waiting 90 seconds, and scanning it using the Vivoo app. The company's proprietary AI technology processes the results and provides personalized insights from dieticians, nutritionists, and doctors.&nbsp;

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

米国発の栄養モニタリングサービス「Vivoo」日本展開、アプリと検査用試薬で健康状態をチェック/大塚製薬

<div>
 
 Vivoo is a passive remote monitoring platform that provides nutrition and lifestyle insights based on 9 health metrics including hydration, pH balance, ketone, and calcium collected through the individual&rsquo;s weekly urine tests. T
 he company's proprietary AI technology processes urine test strips and provides customized health advice within 90 seconds
 from dieticians, nutritionists, and doctors. The platform had nearly 50,000 members across more than 100 countries, as of November 2021.
 
 
 Vivoo has partnerships with Amazon and Walmart to expand its reach. The company invests 20% of its budget in R&amp;D and plans to announce a significant expansion of its platform which will collect three times as much data as before from its proprietary urine test strip technology and integrate with wearable data contained in users' Apple Health and Google Fit apps.
 
 
 In November 2021, the company raised
 USD 6 million in a Series A funding round led by Draper Associates, which was directed towards hiring additional staff to support business growth and expanding its proprietary platform. The company also planned to introduce additional test kits and launch a new premium offering that will track wider user metrics and integrate with wearable data.&nbsp;
 
</div>

Vivoo is a passive remote monitoring platform that provides nutrition and lifestyle insights based on 9 health metrics including hydration, pH balance, ketone, and calcium collected through the individual’s weekly urine tests. The urine analysis process involves users urinating on the test strip, waiting 90 seconds, and scanning it using the Vivoo app. The company's proprietary AI technology processes the results and provides personalized insights from dieticians, nutritionists, and doctors.&nbsp;In <a href="https://sp-edge.com/updates/25309">January 2024</a>, the company introduced an at-home testing kit for urinary tract infections (UTIs) at CES 2024 featuring the utilization of deep learning to ensure speed and accuracy, and the digitalization of test results for easier connection with healthcare providers.&nbsp;Key customers and partnershipsAs of January 2024, the company’s platform was used by nearly 200,000 members across more than 100 countries.&nbsp;Vivoo has also established partnerships with Target, Amazon, and Walmart (to expand its retail presence) and over 10 global distributor partners.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

PROMINENT_CATEGORY

<div>

Vivoo, a remote monitoring platform provider, unveiled a new at-home urinary tract infection (UTI) testing kit at CES 2024. It will be available through Amazon and other outlets by Q2 2024, with prices yet to be announced. The test leverages a urine strip and Vivoo's mobile app for instant results, uses deep learning for speed and accuracy, and digitizes results to ease communication with healthcare providers. Additionally, Vivoo introduced vaginal pH tests.

</div>

Vivoo

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless